[et_pb_section bb_built=”1″ admin_label=”section” fullwidth=”on” next_background_color=”#000000″ global_module=”322″][et_pb_fullwidth_menu global_parent=”322″ _builder_version=”3.0.106″ menu_id=”7″ submenu_direction=”downwards” fullwidth_menu=”off” background_layout=”dark” module_class=”main-navigation” \/][\/et_pb_section][et_pb_section bb_built=”1″ fullwidth=”on” _builder_version=”3.0.47″ prev_background_color=”#000000″ next_background_color=”#000000″][et_pb_fullwidth_slider show_arrows=”off” show_pagination=”off” _builder_version=”3.17.6″ background_position=”top_left” custom_padding=”|||” custom_css_slide_description=”animation: none!important;” custom_css_slide_title=”animation:none!important;” button_text_size__hover_enabled=”off” button_text_size__hover=”null” button_one_text_size__hover_enabled=”off” button_one_text_size__hover=”null” button_two_text_size__hover_enabled=”off” button_two_text_size__hover=”null” button_text_color__hover_enabled=”off” button_text_color__hover=”null” button_one_text_color__hover_enabled=”off” button_one_text_color__hover=”null” button_two_text_color__hover_enabled=”off” button_two_text_color__hover=”null” button_border_width__hover_enabled=”off” button_border_width__hover=”null” button_one_border_width__hover_enabled=”off” button_one_border_width__hover=”null” button_two_border_width__hover_enabled=”off” button_two_border_width__hover=”null” button_border_color__hover_enabled=”off” button_border_color__hover=”null” button_one_border_color__hover_enabled=”off” button_one_border_color__hover=”null” button_two_border_color__hover_enabled=”off” button_two_border_color__hover=”null” button_border_radius__hover_enabled=”off” button_border_radius__hover=”null” button_one_border_radius__hover_enabled=”off” button_one_border_radius__hover=”null” button_two_border_radius__hover_enabled=”off” button_two_border_radius__hover=”null” button_letter_spacing__hover_enabled=”on” button_letter_spacing__hover=”0″ button_one_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover=”null” button_two_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover=”null” button_bg_color__hover_enabled=”off” button_bg_color__hover=”null” button_one_bg_color__hover_enabled=”off” button_one_bg_color__hover=”null” button_two_bg_color__hover_enabled=”off” button_two_bg_color__hover=”null”][et_pb_slide heading=”Manchester Fungal Infection Group” use_bg_overlay=”off” use_text_overlay=”off” _builder_version=”3.17.6″ background_color=”#ffffff” background_image=”https:\/\/sites.manchester.ac.uk\/mfig\/wp-content\/uploads\/sites\/267\/2021\/01\/thomson.jpg” background_position=”top_left” custom_button=”on” button_bg_color=”#27a2db” button_border_color=”#27a2db” button_use_icon=”on” button_on_hover=”on”]<\/p>\n
Understanding and reducing the burden of human fungal diseases.<\/p>\n
[\/et_pb_slide][\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section bb_built=”1″ _builder_version=”3.0.47″ prev_background_color=”#000000″ next_background_color=”#000000″][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″][et_pb_text admin_label=”Spacing only” _builder_version=”3.17.6″]<\/p>\n
<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=”1″ _builder_version=”3.0.47″ prev_background_color=”#000000″ next_background_color=”#1d1d1d”][et_pb_row custom_padding=”3em||0.5em|” parallax_method_1=”off” _builder_version=”3.0.47″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”1_2″][et_pb_text admin_label=”Text: Intro – LHS” _builder_version=”3.17.6″]<\/p>\n
The Manchester Fungal Infection Group (MFIG) is an established international centre of excellence for fungal infection biology and translational antifungal research at The University of Manchester.<\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″][et_pb_text admin_label=”Text: Intro – RHS” _builder_version=”3.17.6″]<\/p>\n
Fungal diseases kill more people annually than tuberculosis or malaria, but are very poorly understood.<\/p>\n
Resistance to frontline antifungal agents is a growing public health concern due to extensive fungicide use in agriculture, and fungal infections are thought to contribute significantly to morbidity in influenza and COVID-19.<\/p>\n
\n“Fungal diseases kill more people annually than tuberculosis or malaria…”<\/span><\/p>\n<\/blockquote>\n
Manchester hosts the largest centre in the world for research into and treatment of fungal respiratory and mucosal diseases, with more than 70 university and NHS staff and students, including 10 academics\/clinician academics.<\/p>\n
[\/et_pb_text][et_pb_divider _builder_version=”3.17.6″]<\/p>\n
[\/et_pb_divider][et_pb_text admin_label=”In-page Nav links” _builder_version=”3.17.6″]<\/p>\n
On this page:<\/strong><\/p>\n
\n
- Major research activities<\/a><\/li>\n
- Key people<\/a><\/li>\n
- Key activities<\/a><\/li>\n
- International impact<\/a><\/li>\n
- Training future scientists and clinicians<\/a><\/li>\n
- Contact us<\/a><\/li>\n<\/ul>\n
[\/et_pb_text][et_pb_divider _builder_version=”3.17.6″]<\/p>\n
[\/et_pb_divider][et_pb_text admin_label=”Text: Intro cont..” _builder_version=”3.17.6″]<\/p>\n
MFIG is the academic research arm of this group and works alongside the National Aspergillosis Centre<\/a>, headed by Dr Chris Kosmidis, and the Mycology Reference Laboratory<\/a>, headed by Dr Riina Richardson. Our combined aim is to understand and reduce the burden of human fungal diseases.<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″][et_pb_text admin_label=”Spacing only” _builder_version=”3.17.6″]<\/p>\n
<\/p>\n
[\/et_pb_text][et_pb_image src=”https:\/\/sites.manchester.ac.uk\/mfig\/wp-content\/uploads\/sites\/267\/2020\/09\/a.fumigatus-spot-assay.jpg” _builder_version=”3.17.6″]<\/p>\n
[\/et_pb_image][et_pb_text admin_label=”Title: Major research activities” _builder_version=”3.17.6″]<\/p>\n
Major research activites<\/h2>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”1_2″][et_pb_text admin_label=”Text: Major research activities – LHS” _builder_version=”3.17.6″]<\/p>\n
Our research builds on a series of high-profile publications and outputs from ongoing projects funded by the MRC, BBSRC, Wellcome Trust and NIH, among others.<\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″][et_pb_text admin_label=”Text: Major research activities – RHS” _builder_version=”3.17.6″]<\/p>\n
Using the human pathogen Aspergillus fumigatus<\/em> as our main experimental system, MFIG’s research is focused on five integrated themes.<\/p>\n
[\/et_pb_text][et_pb_accordion admin_label=”Accordion: Major research activities” _builder_version=”3.17.6″][et_pb_accordion_item title=”Host-pathogen interactions” open=”off” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Our understanding of how fungi invade, regulate and interact with the cells, tissues and systems of the host immune system is limited.<\/p>\n
Our research in this area is broad, and projects are investigating epithelial cell and immune cell interaction with fungi in vitro, as well as with in vivo models within murine or invertebrate hosts and human corneal models of the eye.<\/p>\n
Considerable emphasis is being placed on live-cell imaging and the development of high throughput live-cell screens in these studies.<\/p>\n
Lead:<\/strong><\/p>\n
Dr Margherita Bertuzzi<\/a><\/p>\n
Principal investigators:<\/strong><\/p>\n
\n
- Prof Mike Bromley<\/a><\/li>\n
- Prof Paul Bowyer<\/a><\/li>\n
- Dr Jorge Amich<\/a><\/li>\n
- Dr Sara Gago<\/a><\/li>\n
- Dr Chris Kosmidis<\/a><\/li>\n<\/ul>\n
[\/et_pb_accordion_item][et_pb_accordion_item title=”Genetics and genomics” open=”on” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
All humans inhale hundreds of A. fumigatus<\/em> spores each day, but only a few will develop symptoms of fungal disease.<\/p>\n
Our understanding of the factors that affect susceptibility to aspergillosis and to other fungal diseases is limited. Our research aims to shed light on the genetic aspect of human susceptibility, in order to aid identification of at-risk groups and to help identify host pathways that may benefit from targeted supplementation.<\/p>\n
Lead:<\/strong><\/p>\n
Prof Paul Bowyer<\/a><\/p>\n
Principal investigators:<\/strong><\/p>\n
\n
- Prof Mike Bromley<\/a><\/li>\n
- Dr Margherita Bertuzzi<\/a><\/li>\n
- Dr Sara Gago<\/a><\/li>\n
- Prof David Denning<\/a><\/li>\n
- Dr Jorge Amich<\/a><\/li>\n<\/ul>\n
[\/et_pb_accordion_item][et_pb_accordion_item title=”Novel target development and drug discovery” open=”off” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Many of the current antifungal treatments for chronic fungal infections have multiple distressing side effects.<\/p>\n
There are also few antifungals available to treat invasive fungal diseases, and the last antifungal target for a commercially available antifungal drug was discovered in 1974, with the antifungal being licensed in 2006.<\/p>\n
These facts mean that the need for novel antifungals is as strong as ever. We aim to discover new antifungal drugs with novel modes of action using high throughput screening and advanced live-cell imaging techniques.<\/p>\n
Lead:<\/strong><\/p>\n
Prof Mike Bromley<\/a><\/p>\n
Principal investigators:<\/strong><\/p>\n
\n
- <\/li>\n
- Prof Paul Bowyer<\/a><\/li>\n
- Dr Margherita Bertuzzi<\/a><\/li>\n
- Dr Sara Gago<\/a><\/li>\n
- Prof Lydia Tabernero<\/a><\/li>\n
- Dr Timothy Felton<\/a><\/li>\n
- Dr Norman van Rhijn<\/a><\/li>\n
- Dr Mike Bottery<\/a><\/li>\n<\/ul>\n
[\/et_pb_accordion_item][et_pb_accordion_item title=”Antifungal resistance” open=”off” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Resistance to antifungals (especially azoles) is rapidly increasing. Our research aims to investigate specific resistance mechanisms and how to combat these.<\/p>\n
In Manchester, we have identified a series of target (cyp51A) and non-target (transporters, transcription factors, phosphoregulators and genes involved in mitochondrial function) mechanisms that control resistance to the azole class of antifungals.<\/p>\n
We have employed this knowledge to develop a series of diagnostics to detect resistance in the clinic.<\/p>\n
We are currently leading a multi-centre project to generate a genome-wide knockout collection in A. fumigatus<\/em> to identify further mechanisms of drug resistance and pathogenicity.<\/p>\n
Lead:<\/strong><\/p>\n
Prof Mike Bromley<\/a><\/p>\n
Principal investigators:<\/strong><\/p>\n
\n
- Prof Paul Bowyer<\/a><\/li>\n
- Dr Jorge Amich<\/a><\/li>\n
- Dr Margherita Bertuzzi<\/a><\/li>\n
- Dr Sara Gago<\/a><\/li>\n
- Dr Norman van Rhijn<\/a><\/li>\n
- Dr Mike Bottery<\/a><\/li>\n
- Prof Malcolm Richardson<\/a><\/li>\n
- Dr Lily Novak-Frazer<\/a><\/li>\n
- Dr Riina Richardson<\/a><\/li>\n
- Dr Timothy Felton<\/a><\/li>\n<\/ul>\n
[\/et_pb_accordion_item][et_pb_accordion_item title=”Co-infections in fungal disease” open=”off” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Association between microorganisms is part of an evolutionary strategy to colonise and cause disease in humans.<\/p>\n
As clinical evidence for the common occurrence of combined infection by fungi and other microorganisms increases, research into the mechanism and consequences of their interaction is becoming more relevant.<\/p>\n
Projects in this area are focused on investigating the mechanistic by which viral or bacterial infections contribute to an impaired anti-fungal potency of the epithelium, and the impact of these interactions in the outcome of diseases.\u201d<\/p>\n
Lead:<\/strong><\/p>\n
Dr Sara Gago<\/a><\/p>\n
Principal investigators:<\/strong><\/p>\n
\n
- Prof Mike Bromley<\/a><\/li>\n
- Prof Paul Bowyer<\/a><\/li>\n
- Dr Jorge Amich<\/a><\/li>\n
- Dr Margherita Bertuzzi<\/a><\/li>\n
- Prof Lydia Tabernero<\/a><\/li>\n<\/ul>\n
[\/et_pb_accordion_item][\/et_pb_accordion][et_pb_text admin_label=”Text: Publications” _builder_version=”3.17.6″]<\/p>\n
Research publications<\/h3>\n
View selected publications below, or see a full list in the University Research Explorer<\/a>.<\/p>\n
[\/et_pb_text][et_pb_accordion admin_label=”Accordion: Highlight pubs” _builder_version=”3.17.6″][et_pb_accordion_item title=”Highlight publications” open=”on” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
\n
- \n
Van Rhijn et al. CYP51 Paralogue Structure Is Associated with Intrinsic Azole Resistance in Fungi<\/a><\/span>. mBio. 2021 <\/p>\n<\/li>\n
- \n
van Rhijn et al. The Consequences of Our Changing Environment on Life Threatening and Debilitating Fungal Diseases in Humans<\/a><\/span>. Journal of Fungi 2021<\/p>\n<\/li>\n
- \n
Prattes et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients\u2013 a multinational observational study by the European Confederation of Medical Mycology<\/a><\/span>. Clinical Microbiology and Infection 2021 <\/p>\n<\/li>\n
- \n
Rowley et al. Differential Proinflammatory Responses to Aspergillus fumigatus by Airway Epithelial Cells In Vitro Are Protease Dependent<\/a><\/span>. Journal of Fungi 2021 <\/p>\n<\/li>\n
- \n
Ben Ghazzi et al. Characterisation of Aspergillus fumigatus Endocytic Trafficking within Airway Epithelial Cells Using High-Resolution Automated Quantitative Confocal Microscopy<\/a>. Journal of Fungi 2021<\/p>\n<\/li>\n
- \n
Torre et al. Molecular epidemiology of Aspergillus fumigatus in chronic pulmonary aspergillosis patients<\/a>. Journal of Fungi 2021<\/p>\n<\/li>\n
- \n
Colombo et al. Defective interferon-gamma production is common in chronic pulmonary aspergillosis<\/a><\/span>. The Journal of Infectious Diseases 2021 <\/p>\n<\/li>\n
- \n
Kosmidis et al. Impact of self-reported environmental mould exposure on COPD outcomes<\/a><\/span>. Pulmonology 2021 <\/p>\n<\/li>\n
- \n
Hunter et al. Effect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis<\/a><\/span>. Respiratory Medicine 2021 <\/p>\n<\/li>\n
- \n
Gago et al. CRISPR-Cas9-Mediated Gene Silencing in Cultured Human Epithelia<\/a>. Methods Mol Biol. 2021<\/p>\n<\/li>\n
- \n
Rahman et al. Automated Quantitative Analysis of Airway Epithelial Cell Detachment Upon Fungal Challenge.<\/a> Methods Mol Biol. 2021<\/p>\n<\/li>\n
- \n
Bertuzzi & Howell. Single-Cell Analysis of Fungal Uptake in Cultured Airway Epithelial Cells Using Differential Fluorescent Staining and Imaging Flow Cytometry.<\/a> Methods Mol Biol. 2021<\/p>\n<\/li>\n
- \n
van Rhijn et al. Development of a marker-free mutagenesis system using CRISPR-Cas9 in the pathogenic mould Aspergillus fumigatus<\/em>.<\/a> Fungal Genetics and Biology 2020<\/p>\n<\/li>\n
- \n
Scott et al. Targeting Methionine Synthase in a Fungal Pathogen Causes a Metabolic Imbalance That Impacts Cell Energetics, Growth, and Virulence.<\/a> mBio 2020<\/p>\n<\/li>\n
- \n
Bertuzzi et al. On the lineage of Aspergillus fumigatus<\/em> isolates in common laboratory use.<\/a> Med Mycol. 2020 <\/p>\n<\/li>\n
- \n
Mu\u00f1oz et al. Live-cell imaging of rapid calcium dynamics using fluorescent, genetically-encoded GCaMP probes with Aspergillus fumigatus<\/em>.<\/a> Fungal Genet Biol. 2020 <\/p>\n<\/li>\n
- \n
Seidel et al. Phagolysosomal Survival Enables Non-lytic Hyphal Escape and Ramification Through Lung Epithelium During Aspergillus fumigatus<\/em> Infection.<\/a> Front. Microbiol. 2020 <\/p>\n<\/li>\n
- \n
Amich et al. Three-Dimensional Light Sheet Fluorescence Microscopy of Lungs To Dissect Local Host Immune-Aspergillus<\/em> fumigatus<\/em> Interactions<\/a>. MBio 2020<\/p>\n<\/li>\n
- \n
Furukawa et al. The fungal CCAAT-binding complex and HapX display highly variable but evolutionary conserved synergetic promoter-specific DNA recognition<\/a>. Nucleic Acids Research 2020<\/p>\n<\/li>\n
- \n
Furukawa et al. The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus<\/em><\/a>. Nat Communications 2020<\/p>\n<\/li>\n
- \n
Bowyer et al. Linking calcium signaling and mitochondrial function in fungal drug resistance<\/a>. Proc Natl Acad Sci USA 2020<\/p>\n<\/li>\n
- \n
Page et al. Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation<\/a>. European Respiratory Journal 2019<\/p>\n<\/li>\n
- \n
Bertuzzi et al. Microbial uptake by the respiratory epithelium: outcomes for host and pathogen<\/a>. FEMS Microbiology Reviews 2019<\/p>\n<\/li>\n
- \n
de Castro et al. Aspergillus fumigatus<\/em> calcium-responsive transcription factors regulate cell wall architecture promoting stress tolerance, virulence and caspofungin resistance<\/a>. Plos Genetics 2019<\/p>\n<\/li>\n
- \n
Fraczek et al. Corticosteroid treatment is associated with increased filamentous fungal burden in airways<\/a>. J Allergy Clin Immunol 2018<\/p>\n<\/li>\n
- \n
Gago et al. Lung colonization by Aspergillus fumigatus<\/em> is controlled by ZNF77<\/a>. Nat Communications 2018<\/p>\n<\/li>\n<\/ul>\n
[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″][et_pb_text admin_label=”Spacing only” _builder_version=”3.17.6″]<\/p>\n
<\/p>\n
[\/et_pb_text][et_pb_divider _builder_version=”3.17.6″]<\/p>\n
[\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″][et_pb_text admin_label=”Title: Key people” _builder_version=”3.17.6″]<\/p>\n
Key people<\/h2>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”1_2″][et_pb_text admin_label=”Text: Mike Bromley” _builder_version=”3.17.6″]<\/p>\n
Professor Mike Bromley<\/h3>\n
Director, Manchester Fungal infection Group<\/p>\n
Read Mike’s research profile<\/a><\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″][et_pb_text admin_label=”Text: David Denning” _builder_version=”3.17.6″]<\/p>\n
Professor David Denning<\/h3>\n
Professor of Infectious Diseases in Global Health<\/p>\n
Read David’s research profile<\/a><\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″][et_pb_text admin_label=”Spacing only” _builder_version=”3.17.6″]<\/p>\n
<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”1_2″][et_pb_text admin_label=”Text: Paul Bowyer” _builder_version=”3.17.6″]<\/p>\n
Professor Paul Bowyer<\/h3>\n
Professor in Molecular Biology<\/p>\n
Read Paul’s research profile<\/a><\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″][et_pb_text admin_label=”Text: Malcolm Richardson” _builder_version=”3.17.6″]<\/p>\n
Professor Malcolm Richardson<\/h3>\n
Honorary Professor of Medical Mycology and Consultant Clinical Scientist in Medical Mycology, Mycology Reference Centre<\/p>\n
Read Malcolm’s research profile<\/a><\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″][et_pb_text admin_label=”Spacing only” _builder_version=”3.17.6″]<\/p>\n
<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”1_2″][et_pb_text admin_label=”Text: Paul Bowyer” _builder_version=”3.17.6″]<\/p>\n
Dr Riina Richardson<\/h3>\n
Clinical Senior Lecturer and Consultant for the Manchester University NHS Foundation Trust (MFT)<\/p>\n
Read Riina’s research profile<\/a><\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″][et_pb_text _builder_version=”3.17.6″]<\/p>\n
Dr Margherita Bertuzzi<\/h3>\n
Lecturer in Molecular Microbiology<\/p>\n
Read Margherita’s research profile<\/a><\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″][et_pb_text admin_label=”Spacing only” _builder_version=”3.17.6″]<\/p>\n
<\/p>\n
[\/et_pb_text][et_pb_image src=”https:\/\/sites.manchester.ac.uk\/mfig\/wp-content\/uploads\/sites\/267\/2020\/09\/a.fumigatus-plate.jpg” _builder_version=”3.17.6″]<\/p>\n
[\/et_pb_image][et_pb_text admin_label=”Title: Partnerships” _builder_version=”3.17.6″]<\/p>\n
Key activities<\/h2>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.0.48″ background_size=”%22initial%22″ background_position=”%22top_left%22″ background_repeat=”%22repeat%22″][et_pb_column type=”1_2″][et_pb_text admin_label=”%22Text:” _builder_version=”3.0.74″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”]<\/p>\n
MFIG is part of the wider Manchester Fungal Diseases Group. This means that we work closely with the National Aspergillosis Centre and the Mycology Reference Centre.\u00a0We also work collaboratively with a number of research groups around the world.<\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″][et_pb_text admin_label=”Text: Partnerships – RHS” _builder_version=”3.17.6″]<\/p>\n
In addition, we pride ourselves on our collaborations with industrial partners.<\/p>\n
These take many forms and include:<\/p>\n
\n
- research collaborations<\/li>\n
- sponsorship of CASE studentships<\/li>\n
- licensing partnerships<\/li>\n
- contract research for companies.<\/li>\n<\/ul>\n
Our partners include:<\/p>\n
\n
- Pfizer<\/li>\n
- Du Pont<\/li>\n
- Blueberry Therapeutics<\/li>\n
- F2G<\/li>\n
- Syngenta<\/li>\n
- Pharmacelsus<\/li>\n
- PiQ Laboratories<\/li>\n
- Gilead<\/li>\n
- Synlab<\/li>\n
- Syngenics<\/li>\n
- Pulmocide<\/li>\n<\/ul>\n